We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Status: Archived
Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Updated: 1/1/1970
Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis
Status: Archived
Updated: 1/1/1970
A Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
A Randomized, Prospective, Multi-center, Patient-masked, Bilateral Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
Status: Archived
A Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
Updated: 1/1/1970
A Randomized, Prospective, Multi-center, Patient-masked, Bilateral Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
Status: Archived
Updated: 1/1/1970
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Status: Archived
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Updated: 1/1/1970
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Status: Archived
Updated: 1/1/1970
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
Study to Assess the Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
Updated: 1/1/1970
Study to Assess the Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
Updated: 1/1/1970
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
Status: Archived
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
A Two Arm Prospective, Randomized, Double-Masked Clinical Evaluation of Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
Status: Archived
Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
Updated: 1/1/1970
A Two Arm Prospective, Randomized, Double-Masked Clinical Evaluation of Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
Status: Archived
Updated: 1/1/1970
The Effects of a Single Intravenous Administration of AIN457 or ACZ885 in Dry Eye Patients
A Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study of Intravenous ACZ885 or AIN457 in Dry Eye Syndrome
Status: Archived
The Effects of a Single Intravenous Administration of AIN457 or ACZ885 in Dry Eye Patients
Updated: 1/1/1970
A Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study of Intravenous ACZ885 or AIN457 in Dry Eye Syndrome
Status: Archived
Updated: 1/1/1970
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Updated: 1/1/1970
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
Updated: 1/1/1970
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Updated: 1/1/1970
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study
Status: Archived
Updated: 1/1/1970
Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline
Status: Archived
Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Evaluation of Silicone Hydrogel Lens Wettability With Marketed Lens Care Solutions
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Archived
Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Intraocular Pressure Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Status: Archived
IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Updated: 1/1/1970
Intraocular Pressure Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
Status: Archived
Updated: 1/1/1970
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease
Status: Archived
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
Updated: 1/1/1970
A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Updated: 1/1/1970
A Multicenter, Open Label, Single Ascending Dose Study to Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
A Phase 2, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 and 5% MIM-D3 Ophthalmic Solutions in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model
Status: Archived
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
Updated: 1/1/1970
A Phase 2, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 and 5% MIM-D3 Ophthalmic Solutions in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model
Status: Archived
Updated: 1/1/1970
Tissue Studies of Human Eye Diseases
Updated: 12/31/1969
Immunopathology and Molecular Pathology of Ocular Diseases in Humans
Status: Enrolling
Updated: 12/31/1969
Tissue Studies of Human Eye Diseases
Updated: 12/31/1969
Immunopathology and Molecular Pathology of Ocular Diseases in Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Natural History and Genetic Studies of Usher Syndrome
Updated: 12/31/1969
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated: 12/31/1969
Natural History and Genetic Studies of Usher Syndrome
Updated: 12/31/1969
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Natural History and Genetic Studies of Usher Syndrome
Updated: 12/31/1969
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated: 12/31/1969
Natural History and Genetic Studies of Usher Syndrome
Updated: 12/31/1969
Natural History and Genetic Studies of Usher Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical and Genetic Studies in Families With Myopia and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Clinical and Genetic Studies in Families With Myopia and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical and Genetic Studies in Families With Myopia and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Clinical and Genetic Studies in Families With Myopia and Related Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Myopia and Related Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Novel Diagnostics for Ocular Structure
Updated: 12/31/1969
Optical Coherence Tomography Domain Reflectometry & Optical Coherence Tomography Measurements of Intraocular Structure
Status: Enrolling
Updated: 12/31/1969
Novel Diagnostics for Ocular Structure
Updated: 12/31/1969
Optical Coherence Tomography Domain Reflectometry & Optical Coherence Tomography Measurements of Intraocular Structure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Updated: 12/31/1969
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated: 12/31/1969
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Updated: 12/31/1969
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Updated: 12/31/1969
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated: 12/31/1969
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Updated: 12/31/1969
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Updated: 12/31/1969
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Status: Enrolling
Updated: 12/31/1969
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Updated: 12/31/1969
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases
Updated: 12/31/1969
Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases
Updated: 12/31/1969
Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Updated: 12/31/1969
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Repository for Inherited Eye Diseases
Updated: 12/31/1969
National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
